Gene: NYX
Official Full Name: nyctalopinprovided by HGNC
Gene Summary: The product of this gene belongs to the small leucine-rich proteoglycan (SLRP) family of proteins. Defects in this gene are the cause of congenital stationary night blindness type 1 (CSNB1), also called X-linked congenital stationary night blindness (XLCSNB). CSNB1 is a rare inherited retinal disorder characterized by impaired scotopic vision, myopia, hyperopia, nystagmus and reduced visual acuity. The role of other SLRP proteins suggests that mutations in this gene disrupt developing retinal interconnections involving the ON-bipolar cells, leading to the visual losses seen in patients with complete CSNB. [provided by RefSeq, Oct 2008]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA01673 | NYX Knockout cell line (293T) | Human | NYX | 1:3~1:6 | negative | Online Inquiry |
| KOA07784 | NYX Knockout cell line (AC16) | Human | NYX | 1:3-1:4 | negative | Online Inquiry |
| KOA23229 | NYX Knockout cell line (BEAS-2B) | Human | NYX | 1:3~1:4 | negative | Online Inquiry |
| KOA38677 | NYX Knockout cell line (U-2932) | Human | NYX | 1:2-1:4 | negative | Online Inquiry |
| KOA54074 | NYX Knockout cell line (TPC-1) | Human | NYX | 1:5-1:8 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.